CompletedNot Applicable

Open-Label Placebo for Non-Specific Pain in the ED

Switzerland57 participantsStarted 2024-05-23

Plain-language summary

The aim of this study is to assess whether an intervention with open-label placebo (OLP) for non-specific pain in the emergency department is feasible.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Established diagnosis of non-specific acute pain * Able to understand the study and its outcome measures * Signed informed consent * 18 years or older * Sufficient German language skills Exclusion Criteria: * Chronic pain * Treatment with pain medication for \> 7 days prior to ED visit * Known allergy or intolerance to ibuprofen * Known hereditary galactose-intolerance, lactase deficiency or glucosegalactose malabsorption * Participation in another clinical trial with medicinal products * Need for hospitalization * Known pregnancy

What they're measuring

Rate of eligible patients consenting to participate

Timeframe: 12 months

Rate of patients adhering to the study protocol in terms of medication intake

Timeframe: 7 days

Rate of patients completing their outcome (self-)assessments (i.e. questionnaires)

Timeframe: 30 days

Rate of patients' satisfaction with the intervention and study procedure

Timeframe: 30 days

Trial details

NCT IDNCT06408519

SponsorBruno Minotti

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-13

View on ClinicalTrials.gov More Pain, Acute trials